XML 115 R55.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Notes to the consolidated financial statements - Grants with government agencies and similar bodies (Details) € in Thousands, $ in Thousands, item in Millions | 1 Months Ended | 12 Months Ended | 24 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | ---
Oct. 31, 2021 EUR (€) | Dec. 31, 2020 EUR (€) | Dec. 31, 2020 USD ($) | Nov. 30, 2020 EUR (€) item | Nov. 30, 2020 USD ($) item | Aug. 31, 2019 EUR (€) | Aug. 31, 2019 USD ($) | Feb. 28, 2019 USD ($) | Nov. 30, 2017 EUR (€) | Nov. 30, 2017 USD ($) | Nov. 30, 2016 EUR (€) | Nov. 30, 2016 USD ($) | Dec. 31, 2023 EUR (€) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2021 EUR (€) | Dec. 31, 2021 EUR (€) | Jul. 31, 2020 EUR (€) | May 31, 2020 USD ($) | Jan. 31, 2020 USD ($)
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from release of governmental contract liabilities | € 574,502 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 574,502 |  |  |  |
Receipts from grants from government agencies and similar bodies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 93,531 |  |  |  |
Advance Purchase Agreement with European Commission |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of doses of SARS-CoV-2 advance purchase by the Member States under agreement | item |  |  |  | 225 | 225 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront Payment Received | 450,000 |  |  | € 450,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment of accrued other liabilities of upfront payment |  |  |  |  |  |  |  |  |  |  |  |  | € 4,114 |  |  |  |  |  |  |
Maximum grant | € 0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued other liability for up-front payment |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 4,114 |  |  |  |  |
GSK |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation consist for set-up activities |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20,500 |  |  |  |  |
Reimbursement of prepayments |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,000 |  |  |  |  |
German Federal Ministry of Education and Research |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Remaining grant income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 65,000 |  |  |  |
Income from release of governmental contract liabilities |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  | 0 | 65,218 |  |  |  |
Maximum grant |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 252,000 |  |
Milestone payment received |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 196,300 |  |  |
German Federal Ministry of Education and Research | Miscellaneous other operating income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Remaining grant income |  |  |  |  |  |  |  |  |  |  |  |  | 3,064 |  |  |  |  |  |  |
Coalition for Epidemic Preparedness Innovations |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum grant | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 15,300 | $ 8,300
Maximum amount under the partnership agreement | $ |  |  |  |  |  |  |  | $ 34,000 |  |  |  |  |  |  |  |  |  |  |  |
Term of the partnership agreement |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |  |
Period for which the costs are to be covered |  |  |  |  |  |  |  | 6 months |  |  |  |  |  |  |  |  |  |  |  |
Reimbursement of approved expenses |  |  |  |  |  |  |  |  |  |  |  |  | 3 |  | 42 | 688 |  |  |  |
Grants received and deferred |  |  |  |  |  |  |  |  |  |  |  |  | 305 |  | 309 |  |  |  |  |
Maximum unspent funds reimbursable | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,000 |  |  |  |  |  |
Bill & Melinda Gates Foundation (BMGF) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Receipts from grants from government agencies and similar bodies |  |  |  |  |  |  |  |  |  |  | € 614 | $ 653 |  |  |  |  |  |  |  |
Number of additional grants received |  |  |  |  |  |  |  |  | 2 | 2 |  |  |  |  |  |  |  |  |  |
Amortization of the grants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 488 |  |  |  |
Repayment of grant received from government |  |  |  |  |  |  |  |  |  |  |  |  | 217 |  |  |  |  |  |  |
Grants received and deferred |  |  |  |  |  |  |  |  |  |  |  |  | 1,430 |  |  |  |  |  |  |
Bill & Melinda Gates Foundation (BMGF), Grant for development of a universal influenza vaccine |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Receipts from grants from government agencies and similar bodies |  |  |  | 280 | $ 322 | € 486 | $ 540 |  | € 852 | $ 1,000 |  |  |  |  |  |  |  |  |  |
Bill & Melinda Gates Foundation (BMGF), Grant for malaria vaccine |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Receipts from grants from government agencies and similar bodies |  | € 1,208 | $ 1,449 | € 1,208 | $ 1,449 |  |  |  | € 673 | $ 800 |  |  |  |  |  |  |  |  |  |
Amortization of the grants |  |  |  |  |  |  |  |  |  |  |  |  | € 66 |  | 167 |  |  |  |  |
Grants received and deferred |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 1,712 |  |  |  |  |
Bundesministerium fr Bildung und Forschung |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes to the consolidated financial statements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from release of governmental contract liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 124,000 |  |  |  |

X
- Definition The amount of accrued other liability for up-front payment. + References No definition available. + Details
Name: | cvac_AccruedOtherLiabilityForUpFrontPayment
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of amortization of the grants. + References No definition available. + Details
Name: | cvac_AmortizationOfGovernmentGrants
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the amount of income recognized on compensation for contract manufacturing organizations transfer which is mainly for consideration for set-up activities. + References No definition available. + Details
Name: | cvac_CompensationForContractManufacturingOrganizationsTransferConsiderationForSetUpActivities
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the amount of income recognized on compensation for contract manufacturing organizations transfer which is mainly for Manufacturing Interim Period Reimbursable Expenses. + References No definition available. + Details
Name: | cvac_CompensationForContractManufacturingOrganizationsTransferManufacturingInterimPeriodReimbursableExpenses
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | cvac_DisclosureOfGovernmentGrantsLineItems
Namespace Prefix: | cvac_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of milestone payment received. + References No definition available. + Details
Name: | cvac_IfrsMilestonePaymentReceived
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of remaining grant income classified as other operating income. + References No definition available. + Details
Name: | cvac_IfrsRemainingGrantIncome
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of maximum grant receivable. + References No definition available. + Details
Name: | cvac_MaximumGrantToBeReceived
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of maximum unspent funds reimbursable. + References No definition available. + Details
Name: | cvac_MaximumUnspentFundsReimbursable
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of additional grants received by the company. + References No definition available. + Details
Name: | cvac_NumberOfAdditionalGrantsReceived
Namespace Prefix: | cvac_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of doses of SARS-CoV-2 advance purchase by the Member States under agreement. + References No definition available. + Details
Name: | cvac_NumberOfDosesOfSarsCov2CanBePurchasedByMemberStatesUnderAdvancePurchaseAgreement
Namespace Prefix: | cvac_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum amount agreed under the partnership agreement. + References No definition available. + Details
Name: | cvac_PartnershipAgreementMaximumAmount
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Period for which the costs are to be covered by the funds received under the partnership agreement. + References No definition available. + Details
Name: | cvac_PartnershipAgreementPeriodOfCostsToBeCovered
Namespace Prefix: | cvac_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Term of the partnership agreement. + References No definition available. + Details
Name: | cvac_PartnershipAgreementTerm
Namespace Prefix: | cvac_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of payment of accrued other liabilities of upfront payment. + References No definition available. + Details
Name: | cvac_PaymentOfAccruedOtherLiabilitiesOfUpfrontPayment
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash inflow from government grants and similar bodies. + References No definition available. + Details
Name: | cvac_ReceiptsFromGovernmentGrantsClassifiedAsOperatingActivities
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of reimbursement of approved expenses + References No definition available. + Details
Name: | cvac_ReimbursementOfApprovedExpenses
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow for repayment of received government grant. + References No definition available. + Details
Name: | cvac_RepaymentOfGrantReceivedFromGovernment
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of upfront payment received. + References No definition available. + Details
Name: | cvac_UpfrontPaymentReceived
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_GovernmentGrants
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of income recognised in relation to government grants. [Refer: Government grants] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 20 -IssueDate 2023-01-01 -Paragraph 39 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_RevenueFromGovernmentGrants
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | cvac_IfrsTypeOfArrangementAxis=cvac_AdvancedPurchaseAgreementWithEuropeanCommissionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cvac_GlaxosmithklineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cvac_GovernmentGrantsAxis=cvac_GermanFederalMinistryOfEducationAndResearchMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cvac_IfrsIncomeStatementLocationAxis=cvac_MiscellaneousOtherOperatingIncomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cvac_GovernmentGrantsAxis=cvac_CoalitionForEpidemicPreparednessInnovationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cvac_GovernmentGrantsAxis=cvac_BillAndMelindaGatesFoundationBmgfMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cvac_GovernmentGrantsAxis=cvac_BillMelindaGatesFoundationBmgfGrantForDevelopmentOfUniversalInfluenzaVaccineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cvac_GovernmentGrantsAxis=cvac_BillMelindaGatesFoundationBmgfGrantForMalariaVaccineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cvac_GovernmentGrantsAxis=cvac_BundesministeriumFurBildungUndForschungMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |